Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02614495
Recruitment Status : Completed
First Posted : November 25, 2015
Last Update Posted : February 13, 2020
Sponsor:
Information provided by (Responsible Party):
Hutchison Medipharma Limited

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 30, 2018
Actual Study Completion Date : September 30, 2018